Related Experiment Video
Updated: Jul 15, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Alternatives to placebo-controlled trials
1Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Summary
New drug trials face ethical challenges with placebo controls when effective treatments exist. Active-controlled trials, including non-inferiority studies, are preferred but have methodological concerns.
Area of Science:
- Clinical Trials Methodology
- Medical Ethics
- Pharmacoeconomics
Background:
- Placebo-controlled randomized clinical trials (RCTs) were the standard for drug efficacy assessment.
- Ethical concerns arise when using placebos for new drugs if effective treatments are already available.
- Testing against placebo alone does not guarantee a new drug's superiority over existing options.
Purpose of the Study:
- To discuss the shift from placebo-controlled to active-controlled trials for new medications.
- To analyze the different types of active-controlled trials: superiority, equivalence, and non-inferiority.
- To highlight the methodological challenges and ethical considerations associated with these trial designs.
Main Methods:
- Review of existing literature and ethical guidelines on clinical trial design.
- Analysis of the statistical and methodological aspects of superiority, equivalence, and non-inferiority trials.
- Discussion of "add-on trials" and the potential inclusion of a placebo arm.
Main Results:
- Active-controlled trials are increasingly recommended due to ethical concerns with placebo use.
- Non-inferiority trials are common due to smaller sample size requirements but present methodological issues.
- Concerns include arbitrary equivalence intervals, potential for reduced effectiveness over time, and difficulty in assessing true equivalence or non-inferiority.
Conclusions:
- Methodological rigor is crucial in active-controlled trials to ensure reliable results.
- The paper recommends at least a three-arm trial, including a placebo, even when active comparators exist.
- Ethical considerations for placebo use must be carefully weighed against the need for robust clinical trial data.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...